RE:stockbaboon, 4.50? issued 2 weeks ago,it was a 1 year targetStups you keep talking about Piper and their $4.50 estimate going forward; two weeks before FDA approval.
Piper is actually the closest of the four analysts. It was you predictinf $50 CDN on FDA approval, such a clown.
Stop posting six month old price targets, things have changed.
$7.75
Based on analysts offering 12 month price targets for LMNL in the last 3 months. The average price target is $7.75 with a high estimate of $11 and a low estimate of $4.5
realstocky wrote: we're trading near 5$, u should be happy, lmnl is overperforming like a moda foka:) Wait til they annouce the selling of the riplazym voucher for +- 100M$.... u and piper will look like super geniuses.